- Home
- NATR vs OLMA Comparison
NATR vs OLMA Comparison
Compare NATR & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NATR
- OLMA
- Stock Information
- Founded
- NATR 1972
- OLMA 2006
- Country
- NATR United States
- OLMA United States
- Employees
- NATR N/A
- OLMA N/A
- Industry
- NATR Biotechnology: Pharmaceutical Preparations
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- NATR Health Care
- OLMA Health Care
- Exchange
- NATR Nasdaq
- OLMA Nasdaq
- Market Cap
- NATR 269.6M
- OLMA 299.7M
- IPO Year
- NATR N/A
- OLMA 2020
- Fundamental
- Price
- NATR $15.59
- OLMA $4.57
- Analyst Decision
- NATR Strong Buy
- OLMA Strong Buy
- Analyst Count
- NATR 2
- OLMA 4
- Target Price
- NATR $18.50
- OLMA $24.50
- AVG Volume (30 Days)
- NATR 116.4K
- OLMA 962.9K
- Earning Date
- NATR 08-07-2025
- OLMA 08-05-2025
- Dividend Yield
- NATR N/A
- OLMA N/A
- EPS Growth
- NATR N/A
- OLMA N/A
- EPS
- NATR 0.53
- OLMA N/A
- Revenue
- NATR $456,619,000.00
- OLMA N/A
- Revenue This Year
- NATR $3.08
- OLMA N/A
- Revenue Next Year
- NATR $2.41
- OLMA N/A
- P/E Ratio
- NATR $29.49
- OLMA N/A
- Revenue Growth
- NATR 2.00
- OLMA N/A
- 52 Week Low
- NATR $10.81
- OLMA $2.86
- 52 Week High
- NATR $18.06
- OLMA $16.62
- Technical
- Relative Strength Index (RSI)
- NATR 61.56
- OLMA 52.70
- Support Level
- NATR $13.39
- OLMA $4.12
- Resistance Level
- NATR $14.92
- OLMA $4.70
- Average True Range (ATR)
- NATR 0.52
- OLMA 0.31
- MACD
- NATR 0.02
- OLMA 0.04
- Stochastic Oscillator
- NATR 94.50
- OLMA 74.73
About NATR Nature's Sunshine Products Inc.
Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.